RE:For you AEZS shareholderAezs's shareholders think about it very seriously.
One thing is for sure , Gilles Gagnon doest not have the skills to manage AEZS it is defently to complicated for him , he can't even manage the sale of a natural product (aventramide) that has no competitor.
He was also not capable of managing a clinical study involving Oat beta glucan so how will he do to manage cliniclals studies in NMOSD AND PD.